Oxygenta Pharmaceutical Limited (BOM:524636)
India · Delayed Price · Currency is INR 54.32
-0.89 (-1.61%)
At close: May 6, 2026
Oxygenta Pharmaceutical Market Cap
Oxygenta Pharmaceutical has a market cap or net worth of 2.01 billion as of May 6, 2026. Its market cap has decreased by -27.86% in one year.
Market Cap
2.01B
Enterprise Value
2.72B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
54.32
Market Cap Chart
Since June 4, 1997, Oxygenta Pharmaceutical's market cap has increased from 7.22M to 2.01B, an increase of 27,737.47%. That is a compound annual growth rate of 21.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 2.01B | -2.63% |
| Dec 31, 2025 | 2.06B | -36.22% |
| Dec 31, 2024 | 3.23B | 210.06% |
| Dec 29, 2023 | 1.04B | 159.15% |
| Dec 30, 2022 | 402.61M | 2.53% |
| Dec 31, 2021 | 392.67M | 307.32% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kerala Ayurveda | 2.68B |
| Speciality Medicines | 2.65B |
| Everest Organics | 2.55B |
| Gennex Laboratories | 2.50B |
| Ambalal Sarabhai Enterprises | 2.40B |
| BDH Industries | 2.18B |
| Sanjivani Paranteral | 2.06B |
| Parnax Lab | 1.84B |